SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway

Structure-specific recognition protein 1 (SSRP1) has been considered as a potential biomarker, since aberrant high expression of SSRP1 has been detected in numerous malignant tumors. However, the correlation between the expression level of SSRP1 and glioma remains unclear. The present study attempte...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Rep
Egile Nagusiak: Liao, Jianming, Tao, Xiang, Ding, Qianshan, Liu, Junhui, Yang, Xue, Yuan, Fan-En, Yang, Ji-An, Liu, Baohui, Xiang, Guo-An, Chen, Qianxue
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2017
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780019/
https://ncbi.nlm.nih.gov/pubmed/29048646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5982
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak